Why Most Field-of-Use Restrictions in License Agreements Create More Problems Than They Solve

Field-of-use restrictions sound sensible on paper. Carve the technology into neat slices, license each slice to the party best positioned to develop it, maximize reach. Technology transfer offices love the logic. So do licensing attorneys who bill by the clause.

Photo by nicholas hatherly on Pexels.

In practice, these restrictions quietly kill deals for years before anyone notices.

Here's the core problem: nobody knows where a technology will actually land until someone tries to commercialize it. A drug delivery platform licensed narrowly for oncology might turn out to be most valuable in ophthalmology. A sensor technology restricted to automotive use might have its best market in industrial safety equipment. By the time the licensee figures this out, they're locked out of the application that would actually justify the R&D spend. So they slow-walk development, request modifications that drag on for eighteen months, or quietly let the license lapse.

What started as a strategy to broaden access ends up shrinking it.

The impulse behind field-of-use carving is understandable. Universities want to avoid the scenario where one company parks a broad license and does nothing with it. Exclusive licenses covering a wide field with weak diligence milestones have produced exactly that outcome, repeatedly, and tech transfer offices are right to be wary. But the response to bad exclusivity shouldn't be bureaucratic fragmentation. It should be better diligence terms.

When you set aggressive development milestones tied to specific applications, you don't need to carve the field into pieces. The licensee either hits milestones or loses rights. Simple. The milestones do the work that field-of-use restrictions were supposed to do, without the rigidity.

Consider what field-of-use fragmentation actually requires you to get right upfront: a complete map of all commercially relevant applications, a clear enough technical description to distinguish one field from another in a legal dispute, and licensees for each carved-out field who are ready to move at roughly the same time. You need to be correct about all three simultaneously. That almost never happens at the stage when most licenses are signed.

There's also a market development problem that rarely gets discussed. Technologies with multiple potential applications often require one successful commercial deployment to validate the broader platform. The ophthalmology company won't invest if the oncology company hasn't demonstrated the delivery mechanism works in humans. But the oncology company is under-resourced and moving slowly. Neither field gets developed because neither party has enough incentive to invest in the foundational work that benefits the other.

A better structure in those situations: one licensee with broad rights, robust sublicensing obligations, and milestone gates that require demonstrated progress across specified application areas within defined timeframes. Give the primary licensee the economic incentive to develop the platform fully, then require them to either develop or sublicense non-core fields within a fixed window.

The diagram below sketches how that decision tree should actually look when you're structuring rights:

graph TD
    A[Technology Disclosed] --> B{Multiple Application Areas?}
    B -->|No| C[Standard Exclusive or Non-Exclusive License]
    B -->|Yes| D{Lead Applicant Identified?}
    D -->|No| E[Non-Exclusive with Option Rights by Field]
    D -->|Yes| F[Broad Exclusive + Sublicense Obligations]
    F --> G{Milestone Performance}
    G -->|Met| H[Rights Retained]
    G -->|Missed| I[Field Reverts or Sublicense Triggered]

The reversion trigger is the key piece. Rights that automatically revert when milestones are missed, without requiring litigation or prolonged negotiation, give the university real leverage. Field-of-use restrictions, by contrast, give the university the illusion of control while creating a legal ambiguity problem: what exactly constitutes the "automotive" field when a sensor platform gets adapted for drone navigation?

Licensing disputes over field definitions are expensive, slow, and corrosive to the relationship between the university and the licensee. Nobody wins except the lawyers.

One more thing worth saying plainly: the universities that write the cleanest, most commercially workable licenses attract better licensees over time. Sophisticated operators know which tech transfer offices they can close a deal with efficiently and which ones will bury them in protective clauses that make development economically irrational. Reputation compounds. Restrictive licensing practices don't just hurt individual deals; they shape who shows up to the table next time.

Get the milestones right. Get the reversion triggers right. Then let the licensee figure out where the technology actually works best. That's the whole job.